Literature DB >> 3716765

Presenting signs and symptoms in multiple sclerosis.

E A Sanders, E L Bollen, E A van der Velde.   

Abstract

The disability outcome related to the presenting signs and symptoms was studied retrospectively in 193 patients with definite multiple sclerosis (MS). Patients whose first sign was motor weakness were found to be more severely disabled, at all stages throughout the course of the disease, than patients with other presenting signs or symptoms. Patients whose disease manifested initially with sensory disturbances or paraesthesiae proved to be less seriously disabled than other patients at all stages of the disease. A similar tendency was found in patients presenting with optic neuritis (ON) for the first 20 years of the disease; after that, their disability was comparable to that of patients with other presenting complaints. The difference during the first 20 years of the disease is mainly due to the asymptomatic period after initial manifestation of optic neuritis.

Entities:  

Mesh:

Year:  1986        PMID: 3716765     DOI: 10.1111/j.1600-0404.1986.tb03274.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Isolated optic neuritis and its prognosis for multiple sclerosis: a clinical and paraclinical study with evoked potentials. CSF examination and brain MRI.

Authors:  A Ghezzi; V Torri; M Zaffaroni
Journal:  Ital J Neurol Sci       Date:  1996-10

2.  Prognostic criteria in an epidemiological group of patients with multiple sclerosis: an exploratory study.

Authors:  K Lauer; W Firnhaber
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

3.  Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey.

Authors:  Daniela Pohl; Isabell Hennemuth; Rüdiger von Kries; Folker Hanefeld
Journal:  Eur J Pediatr       Date:  2007-01-12       Impact factor: 3.183

4.  Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.

Authors:  S A Hawkins; G V McDonnell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.